» Articles » PMID: 36364841

Quality Appraisal of Nutritional Guidelines to Prevent, Diagnose, and Treat Malnutrition in All Its Forms During Pregnancy

Abstract

This work aimed to identify clinical practice guidelines (CPGs) that include recommendations for the prevention, diagnosis, and treatment of women’s malnutrition during pregnancy and to evaluate the quality of these guidelines using the Appraisal of Guidelines for Research and Evaluation (AGREE II) instrument. We conducted a literature review using PubMed and different websites from January 2009 to February 2021. The quality of the CPGs was independently assessed by reviewers using the AGREE II instrument, which defines guidelines scoring >70% in the overall assessment as “high quality”. The analysis included 43 guidelines. Among the main findings, we identified that only half of the CPGs (51.1%) obtained a final “high quality” evaluation. AGREE II results varied widely across domains and categories. The two domains that obtained the highest scores were scope and purpose with 88.3% (range 39 to 100%) and clarity of presentation with 87.2% (range 25 to 100%). Among the “high quality” CPGs, the best scores were achieved by the three guidelines published by the National Institute of Health and Care Excellence (NICE) and the World Health Organization (WHO). Due to the importance of maternal nutrition in pregnancy, it is essential to join forces to improve the quality of the guidelines, especially in CPGs that do not meet the reference standards for quality.

Citing Articles

Quality appraisal of clinical practice guidelines for the management of Dysphagia after acute stroke.

Gao S, Liu C, Han Q, Dai X, Liu Y, Li K Front Neurol. 2023; 14:1310133.

PMID: 38116112 PMC: 10728278. DOI: 10.3389/fneur.2023.1310133.


A scoping review and critical evaluation of the methodological quality of clinical practice guidelines on nutrition in the preconception.

Ancira-Moreno M, Burrola-Mendez S, Munoz-Manrique C, Omana-Guzman I, Hoyos-Loya E, Trejo-Dominguez A Front Nutr. 2023; 10:1122289.

PMID: 37927499 PMC: 10621738. DOI: 10.3389/fnut.2023.1122289.

References
1.
. (12) Management of diabetes in pregnancy. Diabetes Care. 2014; 38 Suppl:S77-9. DOI: 10.2337/dc15-S015. View

2.
. ACOG Practice Bulletin No 156: Obesity in Pregnancy. Obstet Gynecol. 2015; 126(6):e112-e126. DOI: 10.1097/AOG.0000000000001211. View

3.
Koren G, Carey N, Gagnon R, Maxwell C, Nulman I, Senikas V . RETIRED: Cancer chemotherapy and pregnancy. J Obstet Gynaecol Can. 2013; 35(3):263-278. DOI: 10.1016/S1701-2163(15)30999-3. View

4.
Ryan K, Bain B, Worthington D, James J, Plews D, Mason A . Significant haemoglobinopathies: guidelines for screening and diagnosis. Br J Haematol. 2010; 149(1):35-49. DOI: 10.1111/j.1365-2141.2009.08054.x. View

5.
Lausman A, Kingdom J . Intrauterine growth restriction: screening, diagnosis, and management. J Obstet Gynaecol Can. 2013; 35(8):741-748. DOI: 10.1016/S1701-2163(15)30865-3. View